25名印度儿童在服用被工业溶剂污染的有毒咳嗽糖浆后死亡。 Twenty-five Indian children died after consuming toxic cough syrups contaminated with industrial solvent.

印度中央邦和拉贾斯坦邦的25名儿童死于受危险工业溶剂二乙基甘醇污染的有毒咳嗽糖浆。 Twenty-five children in India died from toxic cough syrups contaminated with diethylene glycol, a dangerous industrial solvent, in Madhya Pradesh and Rajasthan. 这些糖浆由泰米尔纳德邦的Sresan Pharma制成,含有48.6%的DEG,是安全限值的400倍以上。 The syrups, made by Sresan Pharma in Tamil Nadu, contained 48.6% DEG—over 400 times the safe limit. 工厂有严重的违规情况,包括卫生条件差和非药品级材料。 The factory had severe violations, including unhygienic conditions and non-pharmaceutical-grade materials. 尽管过去曾发出警告,而且过去几十年一再出现安全故障,但由于执法不力、缺乏检查员和没有国家召回制度,不安全的糖浆仍然留在市场上。 Despite past warnings and repeated safety failures dating back decades, unsafe syrups remain on the market due to weak enforcement, lack of inspectors, and no national recall system. 2024年,100多家以出口为重点的制造商未能通过质量测试,对监管冲突,包括购买选举债券的制药公司,日益感到担忧。 Over 100 export-focused manufacturers failed quality tests in 2024, and concerns grow over regulatory conflicts, including pharmaceutical firms buying electoral bonds. 专家要求进行紧急改革,包括禁止不合理的儿科配方,填补空缺的监管角色,建立司法调查,以防止今后发生悲剧。 Experts demand urgent reforms, including banning irrational pediatric formulations, filling vacant regulatory roles, and establishing a judicial inquiry to prevent future tragedies.